Old Web
English
Sign In
Acemap
>
Paper
>
Lorlatinib in ALK- or ROS1-rearranged non-small cell lung cancer: an international, multicenter, open-label phase 1 trial
Lorlatinib in ALK- or ROS1-rearranged non-small cell lung cancer: an international, multicenter, open-label phase 1 trial
2017
Alice Tsang Shaw
E. Felip
Todd Michael Bauer
Benjamin Besse
Alejandro Navarro
Sophie Postel-Vinay
Justin F. Gainor
Melissa Lynne Johnson
J. Kimball Dietrich
Leonard Philip James
Jill S. Clancy
Joseph Chen
Jean Francois Martini
Antonello Abbattista
Benjamin Solomon
Keywords:
Cell
ROS1
Lung cancer
Cancer research
Lorlatinib
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]